Noa Therapeutics Overview

  • Year Founded
  • 2022

Year Founded

  • Status
  • Private

  • Employees
  • 9

Employees

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 18

Noa Therapeutics General Information

Description

Developer of small-molecule therapeutics designed to treat chronic inflammatory diseases. The company's technology utilizes a discovery engine to target non-canonical aryl hydrocarbon receptor signaling, enabling pharmaceutical researchers to achieve immune modulation and barrier restoration for the treatment of atopic dermatitis and gastrointestinal conditions.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 101 College Street, MaRS South Tower
  • Suite 200
  • Toronto, Ontario M5G 1L7
  • Canada
+1 (416)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Pharmaceuticals
Vertical(s)
Corporate Office
  • 101 College Street, MaRS South Tower
  • Suite 200
  • Toronto, Ontario M5G 1L7
  • Canada
+1 (416)

Noa Therapeutics Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Noa Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
13. Accelerator/Incubator Completed Pre-Clinical Trials
12. Accelerator/Incubator 01-Jan-2025 Completed Pre-Clinical Trials
11. Seed Round 06-Mar-2024 Completed Pre-Clinical Trials
10. Accelerator/Incubator 01-Jan-2024 Completed Startup
9. Accelerator/Incubator 01-Jan-2023 Completed Startup
8. Seed Round 01-Jan-2023 Completed Startup
7. Accelerator/Incubator 01-Jan-2023 Completed Startup
6. Seed Round 01-Jan-2022 Completed Startup
5. Accelerator/Incubator Completed Startup
4. Accelerator/Incubator Completed Startup
To view Noa Therapeutics’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Noa Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of small-molecule therapeutics designed to treat chronic inflammatory diseases. The company's technology utili
Drug Discovery
Toronto, Canada
9 As of 2026

La Jolla, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Noa Therapeutics Competitors (1)

One of Noa Therapeutics’s competitors is Equillium, a Formerly VC-backed company based in La Jolla, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Equillium Formerly VC-backed La Jolla, CA
You’re viewing 1 of 1 competitors. Get the full list »

Noa Therapeutics Patents

Noa Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2024373426-A1 Physiological function and homeostasis modulating compounds Pending 30-Oct-2023
EP-4801925-A1 Physiological function and homeostasis modulating compounds Pending 30-Oct-2023
WO-2025091117-A1 Physiological function and homeostasis modulating compounds Inactive 30-Oct-2023
AU-2024369445-A1 Physiological function and homeostasis modulating compounds and use thereof Pending 30-Oct-2023
EP-4801924-A1 Physiological function and homeostasis modulating compounds and use thereof Pending 30-Oct-2023 A61K33/38
To view Noa Therapeutics’s complete patent history, request access »

Noa Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Noa Therapeutics Investors (18)

Investor Name Investor Type Holding Investor Since Participating Rounds
Federal Economic Development Agency for Southern Ontario Government Minority
Ontario Genomics Accelerator/Incubator Minority
Angel One Investor Network Angel Group Minority
Golden Triangle Angelnet Angel Group Minority
NorthSpring Capital Partners PE/Buyout Minority
You’re viewing 5 of 18 investors. Get the full list »

Noa Therapeutics FAQs

  • When was Noa Therapeutics founded?

    Noa Therapeutics was founded in 2022.

  • Where is Noa Therapeutics headquartered?

    Noa Therapeutics is headquartered in Toronto, Canada.

  • What is the size of Noa Therapeutics?

    Noa Therapeutics has 9 total employees.

  • What industry is Noa Therapeutics in?

    Noa Therapeutics’s primary industry is Drug Discovery.

  • Is Noa Therapeutics a private or public company?

    Noa Therapeutics is a Private company.

  • What is Noa Therapeutics’s current revenue?

    The current revenue for Noa Therapeutics is .

  • How much funding has Noa Therapeutics raised over time?

    Noa Therapeutics has raised $1.73M.

  • Who are Noa Therapeutics’s investors?

    Federal Economic Development Agency for Southern Ontario, Ontario Genomics, Angel One Investor Network, Golden Triangle Angelnet, and NorthSpring Capital Partners are 5 of 18 investors who have invested in Noa Therapeutics.

  • Who are Noa Therapeutics’s competitors?

    Equillium is a competitor of Noa Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process